A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes Mellitus

Completed · Phase 3

Conditions studied: Diabetes, Diabetes Mellitus, Type 2

In brief

This trial is conducted globally. The aim of the trial is to compare the efficacy and safety of insulin degludec/liraglutide versus insulin glargine in subjects with type 2 diabetes mellitus.

Key facts

Study ID

NCT01952145

Run by

Novo Nordisk A/S

People needed

557

Starts

2013-09-20

Expected to finish

2014-11-04

Last updated by the study team

2019-01-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Novo Nordisk Investigational Site — Los Alamitos, California, United States
• Novo Nordisk Investigational Site — Palm Springs, California, United States
• Novo Nordisk Investigational Site — San Diego, California, United States
• Novo Nordisk Investigational Site — Colorado Springs, Colorado, United States
• Novo Nordisk Investigational Site — Colorado Springs, Colorado, United States
• Novo Nordisk Investigational Site — Bradenton, Florida, United States
• Novo Nordisk Investigational Site — Fort Lauderdale, Florida, United States
• Novo Nordisk Investigational Site — Miami, Florida, United States
• Novo Nordisk Investigational Site — Pembroke Pines, Florida, United States
• Novo Nordisk Investigational Site — Tampa, Florida, United States
• Novo Nordisk Investigational Site — Gurnee, Illinois, United States
• Novo Nordisk Investigational Site — Evansville, Indiana, United States
• Novo Nordisk Investigational Site — Michigan City, Indiana, United States
• Novo Nordisk Investigational Site — Lexington, Kentucky, United States
• Novo Nordisk Investigational Site — Louisville, Kentucky, United States
• Novo Nordisk Investigational Site — Slidell, Louisiana, United States
• Novo Nordisk Investigational Site — Saint Charles, Missouri, United States
• Novo Nordisk Investigational Site — Wilmington, North Carolina, United States
• Novo Nordisk Investigational Site — Franklin, Ohio, United States
• Novo Nordisk Investigational Site — Oklahoma City, Oklahoma, United States
• Novo Nordisk Investigational Site — Oklahoma City, Oklahoma, United States
• Novo Nordisk Investigational Site — Altoona, Pennsylvania, United States
• Novo Nordisk Investigational Site — Philadelphia, Pennsylvania, United States
• Novo Nordisk Investigational Site — Collierville, Tennessee, United States
• Novo Nordisk Investigational Site — Fresno, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.